Sunshine Biopharma Inc (SBFM)

[Hawaii life]

Currently, there are no drugs that can effectively arrest replication of the virus in people who have contracted the illness. On May 22, 2020, Sunshine Biopharma filed a provisional patent application for a library of molecules that were designed to inhibit the coronavirus proteases, thus shutting down the ability of the virus to multiply and cause illness. As part of its land grant tripartite mission, the University of Georgia is committed to creating and applying new knowledge for the public good. UGA’s Center for Drug Discovery, as well as the Colleges of Pharmacy, are excited to be a part of this ground-breaking research related to the discovery of new treatment options for COVID-19.